PPARα reduction is believed to be due to an increased expression/activation of Rho-associated protein kinase (ROCK) and to a reduction in peroxisomes number caused by elevated ROS in NASH [33,34]. Here, PPARA is linked to metabolic dysfunction-associated steatohepatitis.